Making Narrative Statements to Describe Treatment Effects

[1]  Leila C. Kahwati,et al.  Roadmap for Narratively Describing Effects of Interventions in Systematic Reviews , 2020 .

[2]  G. Guyatt,et al.  GRADE guidelines 26: Informative statements to communicate the findings of systematic reviews of interventions. , 2019, Journal of clinical epidemiology.

[3]  Zhen Wang,et al.  Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD: A Systematic Review , 2019 .

[4]  Mark Chignell,et al.  Enhancing the uptake of systematic reviews of effects: what is the best format for health care managers and policy-makers? A mixed-methods study , 2018, Implementation Science.

[5]  S. Whiteside,et al.  Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis , 2017, JAMA pediatrics.

[6]  N. Lazar,et al.  The ASA Statement on p-Values: Context, Process, and Purpose , 2016 .

[7]  Sharon E. Straus,et al.  Barriers and facilitators to uptake of systematic reviews by policy makers and health care managers: a scoping review , 2015, Implementation Science.

[8]  Ian Hargraves,et al.  Decision aids, empowerment, and shared decision making , 2014, BMJ : British Medical Journal.

[9]  G. Guyatt,et al.  How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature. , 2014, JAMA.

[10]  Gordon H Guyatt,et al.  GRADE guidelines: 9. Rating up the quality of evidence. , 2011, Journal of clinical epidemiology.

[11]  Kristian Thorlund,et al.  Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units , 2010, Health and quality of life outcomes.